Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Intensive Medical Therapy for the Prevention of Early Neurological Deterioration in Branch Atheromatous Disease

NCT04824911 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT04824911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04824911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Intensive Medical Therapy for the Prevention of Early Neurological Deterioration in Branch Atheromatous Disease
Lead sponsor
Chang Gung Memorial Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 23, 2021
Completion date
February 28, 2025
Enrollment
376 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, dual antiplatelet therapy, statin